|
|||||
|
|
Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study |
|
| Authors: | Jay M Margolis Robert Fowler Barbara H Johnson Cheryl A Kassed Kristijan Kahler |
| Institution: | (1) Thomson Reuters, 332 Bryn Mawr Ave., Bala Cynwyd, PA 19004, USA;(2) Thomson Reuters, 4301 Connecticut Ave NW, Suite 330, Washington, DC 20008, USA;(3) Health Analytics, LLC, 9200 Rumsey Road, Suite 215, Columbia, MD 21045, USA;(4) Novartis Pharmaceuticals, One Health Plaza, USEH 501/399O, East Hanover, NJ 07936, USA |
| Abstract: | BackgroundThe goal of this research was to compare the demographics, clinical characteristics and treatment patterns for newly diagnosed multiple sclerosis (MS) patients in a commercial managed care population who received disease-modifying drug (DMD) therapy versus those not receiving DMD therapy. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |